208 related articles for article (PubMed ID: 1703299)
1. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
Rubin EM; Ishida BY; Clift SM; Krauss RM
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):434-8. PubMed ID: 1703299
[TBL] [Abstract][Full Text] [Related]
2. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein AI expression and high density lipoprotein distribution in transgenic mice during development.
Golder-Novoselsky E; Forte TM; Nichols AV; Rubin EM
J Biol Chem; 1992 Oct; 267(29):20787-90. PubMed ID: 1383210
[TBL] [Abstract][Full Text] [Related]
4. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
Walsh A; Ito Y; Breslow JL
J Biol Chem; 1989 Apr; 264(11):6488-94. PubMed ID: 2495286
[TBL] [Abstract][Full Text] [Related]
5. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.
Chajek-Shaul T; Hayek T; Walsh A; Breslow JL
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6731-5. PubMed ID: 1907375
[TBL] [Abstract][Full Text] [Related]
6. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice.
Holvoet P; Danloy S; Collen D
Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000
[TBL] [Abstract][Full Text] [Related]
7. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
Li H; Gu S; She M
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
Srivastava RA
Mol Cell Biochem; 2000 Jun; 209(1-2):125-9. PubMed ID: 10942210
[TBL] [Abstract][Full Text] [Related]
9. Structure and stability of apolipoprotein J-containing high-density lipoproteins.
Stuart WD; Krol B; Jenkins SH; Harmony JA
Biochemistry; 1992 Sep; 31(36):8552-9. PubMed ID: 1390641
[TBL] [Abstract][Full Text] [Related]
10. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
[TBL] [Abstract][Full Text] [Related]
11. Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism.
Srivastava RA
Biochem Mol Biol Int; 1994 Sep; 34(2):393-402. PubMed ID: 7849650
[TBL] [Abstract][Full Text] [Related]
12. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.
Schultz JR; Gong EL; McCall MR; Nichols AV; Clift SM; Rubin EM
J Biol Chem; 1992 Oct; 267(30):21630-6. PubMed ID: 1400473
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of human apolipoprotein AI and high-density lipoprotein by fenofibrate in hapoAI and hapoAI-CIII-AIV transgenic mice.
Srivastava RA; He S; Newton RS
Biochim Biophys Acta; 2011 Feb; 1811(2):76-83. PubMed ID: 21081177
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein-specific populations in high density lipoproteins of human cord blood.
Nichols AV; Blanche PJ; Genzel-Boroviczeny O; Forte TM; Gong EL
Biochim Biophys Acta; 1991 Oct; 1085(3):306-4. PubMed ID: 1911864
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition.
Doolittle MH; LeBoeuf RC; Warden CH; Bee LM; Lusis AJ
J Biol Chem; 1990 Sep; 265(27):16380-8. PubMed ID: 2118905
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
Rubin EM; Krauss RM; Spangler EA; Verstuyft JG; Clift SM
Nature; 1991 Sep; 353(6341):265-7. PubMed ID: 1910153
[TBL] [Abstract][Full Text] [Related]
19. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
20. [The implantation of the human ApoAI gene into aged animals].
Frol'kis VV; Kordium VA; Bogatskaia LN; Novikova SN; Shul'zhenko VN; Kostetskiĭ IE; Potapenko RI; Sabko VE; Mozzhukhina TG; Paramonova GI
Dokl Akad Nauk SSSR; 1991; 316(5):1264-7. PubMed ID: 1909232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
